XTX Topco’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$630K Sell
47,819
-12,653
-21% -$157K 0.01% 2241
2026
Q1
$685K Buy
60,472
+3,405
+6% +$37.5K 0.01% 1743
2025
Q4
$457K Buy
57,067
+13,529
+31% +$316K 0.01% 1688
2025
Q3
$0 Buy
+43,538
New +$966K ﹤0.01% 2927
2025
Q2
Sell
-10,600
Closed -$185K 2796
2025
Q1
$185K Buy
+10,600
New +$314K 0.01% 1722
2023
Q4
Sell
-601
Closed -$11K 1858
2023
Q3
$11K Buy
+601
New +$15.1K ﹤0.01% 1418

Other funds holding KRRO

XTX Topco's KRRO Position: Q2 2026 in Review

XTX Topco reduced its Korro Bio (KRRO) stake by 21% in Q2 2026, selling an estimated $157K and leaving 47,819 shares worth $630K. The position accounts for 0.01% of the portfolio, ranked #2241.

XTX Topco first reported a position in KRRO in Q3 2023 and has held it in 6 quarters since. The position peaked at $685K in Q1 2026. 106 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • XTX Topco held 47,819 shares of Korro Bio worth $630K as of Q2 2026.
  • XTX Topco sold 12,653 Korro Bio shares in Q2 2026, an estimated $157K.
  • Korro Bio made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2241 holding.
  • XTX Topco first reported a position in Korro Bio in Q3 2023 and has held it in 6 quarters since.
  • XTX Topco's Korro Bio position peaked at $685K in Q1 2026.
  • 106 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.